CGM Precision Monitoring : Facilitating Stable Outcome of Sepsis Complicated with Diabetic Ketoacidosis
25/12

CGM Precision Monitoring : Facilitating Stable Outcome of Sepsis Complicated with Diabetic Ketoacidosis

A 60‑year‑old male with type 2 diabetes developed sepsis‑induced diabetic ketoacidosis complicated by acute hepatorenal injury. Guided by continuous glucose monitoring (CGM), insulin and subsequent oral agents were titrated. Ketoacidosis resolved and organ functions recovered, with smooth transition to oral hypoglycemic therapy. This case validates CGM for refined management of severe metabolic crisis.

CGM Empowers Obesity and Diabetes Management: Data-Guided Dietary Intervention and Metabolic Function Remodeling
19/12

CGM Empowers Obesity and Diabetes Management: Data-Guided Dietary Intervention and Metabolic Function Remodeling

A 24‑year‑old obese patient with newly‑onset type 2 diabetes complicated by ketosis and non‑alcoholic steatohepatitis received CGM‑guided medication adjustment and low‑GI dietary intervention. His glycemic level and liver function improved, and insulin was successfully withdrawn. This case confirms CGM facilitates precise therapy and helps patients reshape lifestyle.

From Resistance to Trust: CGM Assists Patients with Low Treatment Compliance in Achieving Rapid Blood Glucose Targets and Reversing Metabolic Disorders
10/12

From Resistance to Trust: CGM Assists Patients with Low Treatment Compliance in Achieving Rapid Blood Glucose Targets and Reversing Metabolic Disorders

A 53‑year‑old obese male with newly‑onset type 2 diabetes and ketoacidosis initially rejected CGM with poor glycemic control. Guided by CGM, multiple hypoglycemic regimens were optimized. His blood glucose rapidly reached targets with TIR approaching 100%. This case proves CGM facilitates individualized glycemic management for patients with low compliance.

资料下载

*Name
*Email
Phone
Company/Organization
Position